BIOAGE LABS INC (BIOA) Stock News

NASDAQ:BIOA - Nasdaq - US09077V1008 - Common Stock - Currency: USD

4.55 +0.09 (+2.02%)

After market: 4.55 0 (0%)

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

BIOA Latest News, Press Relases and Analysis

All

Press Releases

17 hours ago - By: BioAge Labs, Inc.

BioAge Labs Announces First Participant Dosed in Phase 1 Clinical Trial of BGE-102, a Novel Brain-Penetrant NLRP3 Inhibitor

17 hours ago - By: BioAge Labs, Inc.

BioAge Labs Announces First Participant Dosed in Phase 1 Clinical Trial of BGE-102, a Novel Brain-Penetrant NLRP3 Inhibitor

9 days ago - By: The Motley Fool

BioAge Labs (BIOA) Q2 Revenue Hits $2.4M

9 days ago - By: BioAge Labs, Inc.

BioAge Labs Reports Second Quarter 2025 Financial Results and Provides Business Updates

9 days ago - By: BioAge Labs, Inc.

BioAge Labs Reports Second Quarter 2025 Financial Results and Provides Business Updates

3 months ago - By: BioAge Labs, Inc.

BioAge Labs to Present at Upcoming Investor Conferences

18 days ago - By: Yahoo Finance

BioAge (BIOA) to Analyze Over 17,000 Biobank Samples for Drug Discovery

a month ago - By: Bragar Eagel & Squire

BIOAGE ALERT: Bragar Eagel & Squire, P.C. is Investigating BioAge Labs, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

2 months ago - By: BioAge Labs, Inc.

BioAge Labs to Present Preclinical Data on APJ Agonism for Diabetic Obesity and Heart Failure at the American Diabetes Association (ADA) 85th Scientific Sessions

2 months ago - By: BioAge Labs, Inc.

BioAge Labs to Present Preclinical Data on APJ Agonism for Diabetic Obesity and Heart Failure at the American Diabetes Association (ADA) 85th Scientific Sessions

2 months ago - By: BioAge Labs, Inc.

BioAge Labs Expands Drug Discovery Platform with Data from Leading European Biobank

2 months ago - By: BioAge Labs, Inc.

BioAge Labs Expands Drug Discovery Platform with Data from Leading European Biobank

2 months ago - By: BioAge Labs, Inc.

BioAge Expands APJ Agonist Pipeline with Oral Small-Molecule and Long-Acting Biologic Candidates

2 months ago - By: BioAge Labs, Inc.

BioAge Expands APJ Agonist Pipeline with Oral Small-Molecule and Long-Acting Biologic Candidates

3 months ago - By: Yahoo Finance - Mentions: TRVI SPT VRT LLY ...

H.C. Wainwright Initiates Coverage of Trevi Therapeutics (TRVI) With Buy Rating

3 months ago - By: BioAge Labs, Inc.

BioAge Labs completes IND-enabling studies for BGE-102, a potent, orally available, brain-penetrant NLRP3 inhibitor, and advances candidate toward the clinic

3 months ago - By: BioAge Labs, Inc.

BioAge Labs completes IND-enabling studies for BGE-102, a potent, orally available, brain-penetrant NLRP3 inhibitor, and advances candidate toward the clinic

3 months ago - By: BioAge Labs, Inc.

BioAge Labs to Present at Upcoming Investor Conferences

3 months ago - By: Bragar Eagel & Squire

BIOAGE ALERT: Bragar Eagel & Squire, P.C. is Investigating BioAge Labs, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

3 months ago - By: BioAge Labs, Inc.

BioAge Labs Reports First Quarter 2025 Financial Results and Provides Business Updates

3 months ago - By: BioAge Labs, Inc.

BioAge Labs Reports First Quarter 2025 Financial Results and Provides Business Updates

4 months ago - By: Grabar Law Office - Mentions: DRVN IART MPWR

Notice to Long-Term Shareholders of BioAge Labs, Inc. (NASDAQ: BIOA); Driven Bands Holdings, Inc. (NASDAQ: DRVN); Integra LifeSciences Holdings Corporation (NASDAQ: IART); and Monolithic Power Systems, Inc. (NASDAQ: MPWR): Grabar Law Office Investigates

4 months ago - By: Grabar Law Office - Mentions: DRVN IART MPWR

Notice to Long-Term Shareholders of BioAge Labs, Inc. (NASDAQ: BIOA); Driven Bands Holdings, Inc. (NASDAQ: DRVN); Integra Lifesciences Holdings Corporation (NASDAQ: IART); and Monolithic Power Systems, Inc. (NASDAQ: MPWR): Grabar Law Office Investigates

4 months ago - By: Yahoo Finance - Mentions: BLK TSLA NVDA AAPL

BioAge Labs, Inc. (BIOA): A Bull Case Theory

4 months ago - By: Yahoo Finance - Mentions: VZ PCLN BKNG NCLH ...

Booking Holdings Inc. (BKNG): A Bull Case Theory

4 months ago - By: Grabar Law Office - Mentions: NSSC TMCI VIRT

Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of BioAge Labs, Inc. (NASDAQ: BIOA); NAPCO Security Technologies, Inc. (NASDAQ: NSSC); Treace Medical Concepts, Inc. (NASDAQ: TMCI); and Virtu Financial Inc. (NASDAQ: VIRT)

5 months ago - By: BioAge Labs, Inc.

BioAge Labs Reports Full Year 2024 Financial Results and Provides Business Updates from the Fourth Quarter of 2024

5 months ago - By: BioAge Labs, Inc.

BioAge Labs Reports Full Year 2024 Financial Results and Provides Business Updates from the Fourth Quarter of 2024

5 months ago - By: DJS Law Group LLP

Final Deadline for the BioAge Labs, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - BIOA

5 months ago - By: THE ROSEN LAW FIRM, P. A.

BIOA Deadline Today: BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Lawsuit

5 months ago - By: The Rosen Law Firm PA

BIOA DEADLINE TODAY: ROSEN, LEADING INVESTOR COUNSEL, Encourages BioAge Labs, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 10 Deadline in Securities Class Action – BIOA

5 months ago - By: The Schall Law Firm

BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Fraud Lawsuit with the Schall Law Firm

5 months ago - By: The Gross Law Firm

BioAge Labs, Inc. Class Action: The Gross Law Firm Reminds BioAge Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025 - BIOA

5 months ago - By: The Law Offices of Frank R. Cruz

Deadline Soon: BioAge Labs, Inc. (BIOA) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

5 months ago - By: The Rosen Law Firm, P.A.

BIOA Deadline: Rosen Law Firm Urges BioAge Labs, Inc. (NASDAQ: BIOA) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

5 months ago - By: Faruqi & Faruqi LLP

Faruqi & Faruqi Reminds BioAge Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025 - BIOA